InsiderTrades

Form 4 for CC Chemours Co

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001209191-23-016094 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-03 2023-03-01 CC Bellezza Alisha Pres, Thermal Spec Solns A - Grant $0.00 +5,919 44.9K +15% $0
DM 2023-03-03 2023-03-01+ CC Bellezza Alisha Pres, Thermal Spec Solns F - Tax $35.66 -1,468 43.9K -3% -$52.4K
DM 2023-03-03 2023-03-01 CC Bellezza Alisha Pres, Thermal Spec Solns A - Grant $0.00 +26.7K 13.2K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-01 A A 5,919 $0.00 44,873.86 D — — (F3) Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. (F2) Includes directly owned shares, restricted stock units and dividend equivalent units.
2 Common Common Stock 2023-03-01 F D 525 $34.84 38,954.86 D — — (F1) Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. (F2) Includes directly owned shares, restricted stock units and dividend equivalent units.
3 Common Common Stock 2023-03-02 F D 943 $36.12 43,930.86 D — — (F1) Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. (F2) Includes directly owned shares, restricted stock units and dividend equivalent units.
4 Derivative Stock Option (Right to Buy) 2023-03-01 A A 13,427 $0.00 13,427 D $34.84 · — to 2033-03-01 13,427 Common Stock (F4) These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.
5 Derivative Performance Stock Option (Right to Buy) 2023-03-01 A A 13,238 $0.00 13,238 D $38.32 · — to 2033-03-01 13,238 Common Stock (F5) Represents a 10 percent premium above the closing price of the Company common stock on the date of grant (F4) These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.